Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (4148)	4/25/1998 9:24:00 PM
From: billkirn	Read Replies (1) \| Respond to of 6136

Thanks for adding you comments Rick. It looks to me like AGPH will trend down for awhile. I was hoping it would break 40. It was unable to reach this level and my guess it will retest its last low before a major up move can begin. As much as this hurts my options, I would not be surprised to see it around 28-30 in a few weeks. Maybe they will announce something great during this time frame to negate this testing stuff. The long term players should really like this stock at 28-30. Bill

To: scaram(o)uche who wrote (4148)	4/26/1998 2:56:00 PM
From: Steve Fancy	Respond to of 6136

Richard, correction in the last paragraph in my post to you... In that I'm sitting on substantial losses on this company, I really appreciate your candid opinions. The bottom line in any investment is money. I'm unclear whether my money is betting on Viracept or the pipeline and I'm not interested in waiting until 2001 plus to recoup my losses. On the other hand, after all the pain, I don't want to jump ship prematurely. Thanks again. sf